Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-03-28
1992-07-21
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514418, 548483, 548484, 548485, 548486, 548492, 548495, 548494, 548495, 548510, C07D20908, A61K 31405
Patent
active
051323192
ABSTRACT:
Compounds having the formula I: ##STR1## are inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis and allograft rejection and in preventing the formation of atherosclerotic plaques.
REFERENCES:
patent: 4822809 (1989-04-01), Summers et al.
patent: 4822811 (1989-04-01), Summers
Delorme Daniel
Fortin Rejean
Girard Yves
Hamel Pierre
DiPrima Joseph F.
Lopez Gabriel
Merck Frosst Canada Inc.
Shah Mukund J.
Venkat Jyothsna
LandOfFree
1-(hydroxylaminoalkyl) indole derivatives as inhibitors of leuko does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-(hydroxylaminoalkyl) indole derivatives as inhibitors of leuko, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-(hydroxylaminoalkyl) indole derivatives as inhibitors of leuko will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-843571